Ignite Creation Date:
2024-05-06 @ 3:51 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04770545
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-26
First Post:
2021-02-23
Brief Title:
An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan APL-2 in Subjects With Geographic Atrophy Secondary to AMD
Sponsor:
Apellis Pharmaceuticals Inc
Organization:
Apellis Pharmaceuticals Inc
Organization Data
Organization:
Apellis Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
APL2-GA-305
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Apellis Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None